ANI Pharmaceuticals ANIP Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $311.21M+9.0% | $285.62M+8.7% | $262.65M+20.6% | $217.83M+45.4% | $149.84M+3.4% | ||
| $255.43M-9.1% | $281.08M+11.3% | $252.62M+11.9% | $225.65M+2.4% | $220.33M-0.6% | ||
| $143.47M+0.3% | $143.07M-2.3% | $146.48M+5.9% | $138.32M+0.7% | $137.41M+0.5% | ||
| $747.08M-0.8% | $753.12M+7.8% | $698.4M+15.9% | $602.63M+12.4% | $536.29M+1.5% | ||
| $67.12M+7.4% | $62.48M-1.7% | $63.56M+7.3% | $59.25M+1.8% | $58.18M+2.3% | ||
| $62.48M0.0% | $62.48M0.0% | $62.48M+3.2% | $60.53M-0.2% | $60.66M+1.1% | ||
| $467.16M-2.6% | $479.53M-4.1% | $499.82M-3.9% | $520.32M-0.5% | $522.7M-3.5% | ||
| $1.42B-1.3% | $1.44B+2.3% | $1.41B+4.9% | $1.34B+3.9% | $1.29B+0.6% | ||
| $69.69M+11.4% | $62.58M-10.3% | $69.8M+27.9% | $54.57M+2.8% | $53.06M+16.2% | ||
| $19.3M+11.8% | $17.27M+13.3% | $15.24M+15.3% | $13.22M+18.1% | $11.19M+22.0% | ||
| $239.51M-13.9% | $278.11M+2.8% | $270.56M+14.2% | $236.84M+17.4% | $201.82M+3.8% | ||
| $286M-2.0% | $291.84M-2.0% | $297.68M-1.3% | $301.48M-1.2% | $305.29M-1.2% | ||
| $859.67M-4.4% | $899.65M-0.3% | $902.34M+2.4% | $881.39M+3.8% | $848.96M-0.8% | ||
| $3K0.0% | $3K0.0% | $3K+50.0% | $2K0.0% | $2K0.0% | ||
| $6.39M+128% | -$23.1M+54.3% | -$50.59M+34.2% | -$76.86M+9.6% | -$85M+15.2% | ||
| $562.3M+4.0% | $540.72M+6.9% | $505.82M+15.8% | $436.76M+4.3% | $418.62M+3.7% | ||
| $1.42B-1.3% | $1.44B+2.3% | $1.41B+4.9% | $1.34B+3.9% | $1.29B+0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ANI Pharmaceuticals's total assets?
- ANI Pharmaceuticals (ANIP) holds $1.4B in total assets, up 10.0% year over year.
- How much debt does ANI Pharmaceuticals have?
- ANI Pharmaceuticals carries $305.3M in total debt against $562.3M of shareholders' equity, a debt-to-equity ratio of 0.54.
- How much cash does ANI Pharmaceuticals have?
- ANI Pharmaceuticals holds $311.2M in cash and equivalents.
- Can ANI Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.12 — current assets exceed current liabilities.
- Where does ANI Pharmaceuticals's balance sheet data come from?
- Every line is extracted from ANI Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
